WELLS FARGO & COMPANY/MN - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$365,000
+49.0%
282,972
+21.3%
0.00%
Q3 2019$245,000
-26.2%
233,355
+19.6%
0.00%
Q2 2019$332,000
-63.5%
195,132
-27.7%
0.00%
Q1 2019$910,000
+78.8%
269,877
+54.7%
0.00%
Q4 2018$509,000
-57.5%
174,458
-10.4%
0.00%
Q3 2018$1,199,000
+1.4%
194,690
+21.5%
0.00%
Q2 2018$1,182,000
+341.0%
160,181
+292.2%
0.00%
Q1 2018$268,000
-50.5%
40,846
-36.4%
0.00%
Q4 2017$541,000
-37.5%
64,230
-14.4%
0.00%
Q3 2017$866,000
-8.6%
75,003
-7.5%
0.00%
Q2 2017$947,000
+0.9%
81,065
+6.6%
0.00%
Q1 2017$939,000
+72.9%
76,081
+91.0%
0.00%
Q4 2016$543,000
+137.1%
39,839
+245.7%
0.00%
Q3 2016$229,000
+301.8%
11,525
+161.9%
0.00%
Q2 2016$57,000
+23.9%
4,400
-11.2%
0.00%
Q1 2016$46,000
-48.9%
4,954
+11.8%
0.00%
Q4 2015$90,000
+40.6%
4,430
-0.1%
0.00%
Q3 2015$64,000
-52.9%
4,434
-30.7%
0.00%
Q2 2015$136,000
+655.6%
6,394
+699.2%
0.00%
Q1 2015$18,0008000.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders